{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:28:55Z","timestamp":1777328935338,"version":"3.51.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T00:00:00Z","timestamp":1368835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00204-013-1057-x","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T06:33:53Z","timestamp":1368772433000},"page":"929-947","source":"Crossref","is-referenced-by-count":29,"title":["Update on 1-benzylpiperazine (BZP) party pills"],"prefix":"10.1007","volume":"87","author":[{"given":"M\u00e1rcia S\u00e1","family":"Monteiro","sequence":"first","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Guedes de Pinho","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,5,18]]},"reference":[{"issue":"4","key":"1057_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ntt.2006.05.005","volume":"28","author":"LK Aitchison","year":"2006","unstructured":"Aitchison LK, Hughes RN (2006) Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects. Neurotoxicol Teratol 28(4):453\u2013458. doi: 10.1016\/j.ntt.2006.05.005","journal-title":"Neurotoxicol Teratol"},{"issue":"1233","key":"1057_CR2","first-page":"U1959","volume":"J119","author":"M Alansari","year":"2006","unstructured":"Alansari M, Hamilton D (2006) Nephrotoxicity of BZP-based herbal party pills: a New Zealand case report. N Z Med J119(1233):U1959","journal-title":"N Z Med"},{"key":"1057_CR3","unstructured":"Antia U (2009) The metabolism and pharmacokinetics of BZP and TFMPP\u2014\u201dparty pill\u201d drugs. Dissertation, University of Auckland"},{"issue":"1307","key":"1057_CR7","first-page":"55","volume":"122","author":"U Antia","year":"2009","unstructured":"Antia U, Tingle MD, Russell BR (2009a) \u2018Party pill\u2019 drugs\u2014BZP and TFMPP. N Z Med J 122(1307):55\u201368","journal-title":"N Z Med J"},{"issue":"1\u20133","key":"1057_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.forsciint.2009.01.015","volume":"186","author":"U Antia","year":"2009","unstructured":"Antia U, Lee HS, Kydd RR, Tingle MD, Russell BR (2009b) Pharmacokinetics of \u2018party pill\u2019 drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Sci Int 186(1\u20133):63\u201367. doi: 10.1016\/j.forsciint.2009.01.015","journal-title":"Forensic Sci Int"},{"issue":"7","key":"1057_CR6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1211\/jpp\/61.07.0006","volume":"61","author":"U Antia","year":"2009","unstructured":"Antia U, Tingle MD, Russell BR (2009c) Metabolic interactions with piperazine-based \u2018party pill\u2019 drugs. J Pharm Pharmacol 61(7):877\u2013882. doi: 10.1211\/jpp\/61.07.0006","journal-title":"J Pharm Pharmacol"},{"issue":"1303","key":"1057_CR5","first-page":"29","volume":"122","author":"U Antia","year":"2009","unstructured":"Antia U, Tingle MD, Russell BR (2009d) In vivo interactions between BZP and TFMPP (party pill drugs). N Z Med J 122(1303):29\u201338","journal-title":"N Z Med J"},{"issue":"5","key":"1057_CR8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1556-4029.2010.01457.x","volume":"55","author":"U Antia","year":"2010","unstructured":"Antia U, Tingle MD, Russell BR (2010) Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. J Forensic Sci 55(5):1311\u20131318. doi: 10.1111\/j.1556-4029.2010.01457.x","journal-title":"J Forensic Sci"},{"issue":"3","key":"1057_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","volume":"122","author":"MD Arbo","year":"2012","unstructured":"Arbo MD, Bastos ML, Carmo HF (2012) Piperazine compounds as drugs of abuse. Drug Alcohol Depend 122(3):174\u2013185. doi: 10.1016\/j.drugalcdep.2011.10.007","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1057_CR10","first-page":"406","volume":"12","author":"H Austin","year":"2004","unstructured":"Austin H, Monasterio E (2004) Acute psychosis following ingestion of \u2018rapture\u2019. Australas Psychiatry 12(4):406\u2013408. doi: 10.1111\/j.1440-1665.2004.02137.x","journal-title":"Australas Psychiatry"},{"issue":"20","key":"1057_CR11","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.chroma.2009.03.033","volume":"1216","author":"F Badoud","year":"2009","unstructured":"Badoud F, Grata E, Perrenoud L et al (2009) Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis. J Chromatogr A 1216(20):4423\u20134433. doi: 10.1016\/j.chroma.2009.03.033","journal-title":"J Chromatogr A"},{"key":"1057_CR12","doi-asserted-by":"crossref","unstructured":"Balmelli C, Kupferschmidt H, Rentsch K, Schneemann M (2001) [Fatal brain edema after ingestion of ecstasy and benzylpiperazine]. Dtsch Med Wochenschr (1946) 126(28\u201329):809\u2013811. doi: 10.1055\/s-2001-15702 [ABSTRACT]","DOI":"10.1055\/s-2001-15702"},{"issue":"9","key":"1057_CR13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/dta.274","volume":"3","author":"M Baron","year":"2011","unstructured":"Baron M, Elie M, Elie L (2011) An analysis of legal highs\u2014do they contain what it says on the tin? Drug Test Anal 3(9):576\u2013581. doi: 10.1002\/dta.274","journal-title":"Drug Test Anal"},{"issue":"40","key":"1057_CR14","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1016\/j.chroma.2010.08.001","volume":"1217","author":"M Barroso","year":"2010","unstructured":"Barroso M, Costa S, Dias M, Vieira DN, Queiroz JA, Lopez-Rivadulla M (2010) Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry. J Chromatogr A 1217(40):6274\u20136280. doi: 10.1016\/j.chroma.2010.08.001","journal-title":"J Chromatogr A"},{"issue":"7\u20138","key":"1057_CR15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/dta.314","volume":"3","author":"T Bassindale","year":"2011","unstructured":"Bassindale T (2011) Benzylpiperazine: the New Zealand legal perspective. Drug Test Anal 3(7\u20138):428\u2013429. doi: 10.1002\/dta.314","journal-title":"Drug Test Anal"},{"key":"1057_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1316.024","volume":"1025","author":"MH Baumann","year":"2004","unstructured":"Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2004) Effects of \u201clegal X\u201d piperazine analogs on dopamine and serotonin release in rat brain. Ann N Y Acad Sci 1025:189\u2013197. doi: 10.1196\/annals.1316.024","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1057_CR17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.npp.1300585","volume":"30","author":"MH Baumann","year":"2005","unstructured":"Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u2018Ecstasy\u2019). Neuropsychopharmacology 30(3):550\u2013560. doi: 10.1038\/sj.npp.1300585","journal-title":"Neuropsychopharmacology"},{"issue":"7\u20138","key":"1057_CR18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/dta.306","volume":"3","author":"C Bell","year":"2011","unstructured":"Bell C, George C, Kicman AT, Traynor A (2011) Development of a rapid LC-MS\/MS method for direct urinalysis of designer drugs. Drug Test Anal 3(7\u20138):496\u2013504. doi: 10.1002\/dta.306","journal-title":"Drug Test Anal"},{"issue":"2","key":"1057_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1797.2011.01537.x","volume":"17","author":"L Berney-Meyer","year":"2012","unstructured":"Berney-Meyer L, Putt T, Schollum J, Walker R (2012) Nephrotoxicity of recreational party drugs. Nephrology (Carlton) 17(2):99\u2013103. doi: 10.1111\/j.1440-1797.2011.01537.x","journal-title":"Nephrology (Carlton)"},{"issue":"2\u20133","key":"1057_CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2006.10.016","volume":"88","author":"K Brennan","year":"2007","unstructured":"Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S (2007) Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA). Drug Alcohol Depend 88(2\u20133):204\u2013213. doi: 10.1016\/j.drugalcdep.2006.10.016","journal-title":"Drug Alcohol Depend"},{"key":"1057_CR21","unstructured":"Bryson K, Wilson M (2007) Recreational drug using behaviour and legal BZP party pills: Report to the National Drug Policy. http:\/\/www.ndp.govt.nz\/moh.nsf\/pagescm\/7494\/$File\/recreational-druguse-bzp-jun08.pdf . Accessed 12 Sept 2012"},{"key":"1057_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4321\/S1137-66272011000200012","volume":"34","author":"G Burillo-Putze","year":"2011","unstructured":"Burillo-Putze G, Climent B, Echarte JL et al (2011) Drogas emergentes (I): las\u00a0\u00ab\u00a0smart drugs\u00bb. An Sist Sanit Navar 34:263\u2013274","journal-title":"An Sist Sanit Navar"},{"key":"1057_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-4-18","volume":"4","author":"RA Butler","year":"2007","unstructured":"Butler RA, Sheridan JL (2007) Highs and lows: patterns of use, positive and negative effects of benzylpiperazine-containing party pills (BZP-party pills) amongst young people in New Zealand. Harm Reduct J 4:18. doi: 10.1186\/1477-7517-4-18","journal-title":"Harm Reduct J"},{"key":"1057_CR24","doi-asserted-by":"crossref","unstructured":"Bye C, Munro-Faure AD, Peck AW, Young PA (1973) A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. Eur J Clin Pharmacol 6(3):163\u2013169. [Abstract] doi: 10.1007\/bf00558280","DOI":"10.1007\/BF00558280"},{"issue":"3","key":"1057_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00558281","volume":"6","author":"H Campbell","year":"1973","unstructured":"Campbell H, Cline W, Evans M, Lloyd J, Peck AW (1973) Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol 6(3):170\u2013176. doi: 10.1007\/bf00558281","journal-title":"Eur J Clin Pharmacol"},{"key":"1057_CR26","unstructured":"Chou K, Antia U, Russell B, Tingle MD (2008) Disposition of \u201cParty pill\u201d drugs BZP and TFMPP in the Sprague-Dawley rat. Poster, Department of Pharmacology and Clinical Pharmacology. School of Pharmacy, University of Auckland [Courtesy of Professor Malcolm Tingle]"},{"issue":"2","key":"1057_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2010.12.002","volume":"22","author":"BM Cohen","year":"2011","unstructured":"Cohen BM, Butler R (2011) BZP-party pills: a review of research on benzylpiperazine as a recreational drug. Int J Drug Policy 22(2):95\u2013101. doi: 10.1016\/j.drugpo.2010.12.002","journal-title":"Int J Drug Policy"},{"issue":"7351","key":"1057_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/474253a","volume":"474","author":"M Cole","year":"2011","unstructured":"Cole M (2011) Poison in party pills is too much to swallow. Nature 474(7351):253","journal-title":"Nature"},{"issue":"7","key":"1057_CR29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","volume":"103","author":"S Davies","year":"2010","unstructured":"Davies S, Wood DM, Smith G et al (2010) Purchasing \u2018legal highs\u2019 on the Internet\u2014is there consistency in what you get? Q J Med 103(7):489\u2013493. doi: 10.1093\/qjmed\/hcq056","journal-title":"Q J Med"},{"issue":"1\u20132","key":"1057_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0379-0738(01)00452-2","volume":"121","author":"D Boer de","year":"2001","unstructured":"de Boer D, Bosman IJ, Hidvegi E et al (2001) Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 121(1\u20132):47\u201356","journal-title":"Forensic Sci Int"},{"issue":"8","key":"1057_CR31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jat\/34.8.464","volume":"34","author":"AJ Dickson","year":"2010","unstructured":"Dickson AJ, Vorce SP, Holler JM, Lyons TP (2010) Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples. J Anal Toxicol 34(8):464\u2013469","journal-title":"J Anal Toxicol"},{"issue":"5","key":"1057_CR32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpba.2010.11.043","volume":"54","author":"G Dowling","year":"2011","unstructured":"Dowling G, Regan L (2011) A new mixed mode solid phase extraction strategy for opioids, cocaines, amphetamines and adulterants in human blood with hybrid liquid chromatography tandem mass spectrometry detection. J Pharm Biomed Anal 54(5):1136\u20131145. doi: 10.1016\/j.jpba.2010.11.043","journal-title":"J Pharm Biomed Anal"},{"issue":"1\u20133","key":"1057_CR33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.forsciint.2011.08.005","volume":"214","author":"L Elie","year":"2012","unstructured":"Elie L, Baron M, Croxton R, Elie M (2012) Microcrystalline identification of selected designer drugs. Forensic Sci Int 214(1\u20133):182\u2013188. doi: 10.1016\/j.forsciint.2011.08.005","journal-title":"Forensic Sci Int"},{"issue":"7\u20138","key":"1057_CR34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/dta.307","volume":"3","author":"S Elliott","year":"2011","unstructured":"Elliott S (2011) Current awareness of piperazines: pharmacology and toxicology. Drug Test Anal 3(7\u20138):430\u2013438. doi: 10.1002\/dta.307","journal-title":"Drug Test Anal"},{"issue":"2","key":"1057_CR35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jat\/32.2.172","volume":"32","author":"S Elliott","year":"2008","unstructured":"Elliott S, Smith C (2008) Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J Anal Toxicol 32(2):172\u2013177","journal-title":"J Anal Toxicol"},{"key":"1057_CR38","unstructured":"EMCDDA (2007a) Risk Assessment Report of a new psychoactive substance: 1-benzylpiperazine (BZP)"},{"key":"1057_CR36","unstructured":"EMCDDA (2007b) European Monitoring Centre for Drugs and Drug Addiction. Europol-EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP)"},{"key":"1057_CR37","unstructured":"EMCDDA (2007c) New drug under formal scrutiny. Council asks EMCDDA to assess risks of BZP. Lisbon. http:\/\/www.emcdda.europa.eu\/news\/2007 . Accessed 12 Apr 2011"},{"key":"1057_CR39","unstructured":"EMCDDA (2008) Council decision: \u201cappropriate controls\u201d for BZP\u2014new drug BZP to be placed under control across the EU. Lisbon. http:\/\/www.emcdda.europa.eu\/news\/2008 . Accessed 12 Apr 2011"},{"key":"1057_CR40","unstructured":"EMCDDA (2010) European Monitoring Centre for Drugs and Drug Addiction. Annual Report on The state of the drugs problem in Europe. http:\/\/www.emcdda.europa.eu\/publications\/annual-report\/2010 . Accessed 12 Apr 2011"},{"key":"1057_CR41","unstructured":"EMCDDA (2011) European Monitoring Centre for Drugs and Drug Addiction. Annual Report on The state of the drugs problem in Europe. http:\/\/www.emcdda.europa.eu\/publications\/annual-report\/2011 . Accessed 26 Aug 2012"},{"issue":"2","key":"1057_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2004.07.014","volume":"77","author":"WE Fantegrossi","year":"2005","unstructured":"Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A (2005) Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend 77(2):161\u2013168. doi: 10.1016\/j.drugalcdep.2004.07.014","journal-title":"Drug Alcohol Depend"},{"key":"1057_CR43","unstructured":"Flanagan GG, Taylor A, Watson IA, Welpton R (2007) Fundamentals of analytical toxicology. Wiley, England, pp 95\u201398; 309\u2013334"},{"key":"1057_CR44","unstructured":"Gee P, Fountain J (2007) Party on? BZP party pills in New Zealand. N Z Med J 120(1249):U2422"},{"issue":"11","key":"1057_CR45","first-page":"12","volume":"11","author":"P Gee","year":"2005","unstructured":"Gee P, Richardson S (2005) Researching the toxicity of party pills. Nurs N Z 11(11):12\u201313","journal-title":"Nurs N Z"},{"issue":"1227","key":"1057_CR46","first-page":"U1784","volume":"118","author":"P Gee","year":"2005","unstructured":"Gee P, Richardson S, Woltersdorf W, Moore G (2005) Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. N Z Med J 118(1227):U1784","journal-title":"N Z Med J"},{"issue":"9","key":"1057_CR47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/15563650802307602","volume":"46","author":"P Gee","year":"2008","unstructured":"Gee P, Gilbert M, Richardson S, Moore G, Paterson S, Graham P (2008) Toxicity from the recreational use of 1-benzylpiperazine. Clin Toxicol (Phila) 46(9):802\u2013807. doi: 10.1080\/15563650802307602","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"1057_CR48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/15563651003592948","volume":"48","author":"P Gee","year":"2010","unstructured":"Gee P, Jerram T, Bowie D (2010) Multiorgan failure from 1-benzylpiperazine ingestion\u2014legal high or lethal high? Clin Toxicol (Phila) 48(3):230\u2013233. doi: 10.3109\/15563651003592948","journal-title":"Clin Toxicol (Phila)"},{"issue":"1283","key":"1057_CR49","first-page":"35","volume":"121","author":"JA Green","year":"2008","unstructured":"Green JA (2008) Partying on? Life after BZP-based party pills. N Z Med J 121(1283):35\u201342","journal-title":"N Z Med J"},{"key":"1057_CR50","unstructured":"Hammond KAB (2008) Recreational drug using behaviour and legal benzylpiperazine party pills. Dissertation, Victoria University of Wellington"},{"issue":"2","key":"1057_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pbb.2008.12.003","volume":"92","author":"CE Herbert","year":"2009","unstructured":"Herbert CE, Hughes RN (2009) A comparison of 1-benzylpiperazine and methamphetamine in their acute effects on anxiety-related behavior of hooded rats. Pharmacol Biochem Behav 92(2):243\u2013250. doi: 10.1016\/j.pbb.2008.12.003","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"1057_CR52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mpmed.2009.08.009","volume":"37","author":"SL Hill","year":"2009","unstructured":"Hill SL, Thomas SHL (2009) What\u2019s new in\u2026 Toxicity of drugs of abuse. Medicine 37(11):621\u2013626","journal-title":"Medicine"},{"issue":"8","key":"1057_CR53","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15563650.2011.615318","volume":"49","author":"SL Hill","year":"2011","unstructured":"Hill SL, Thomas SH (2011) Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 49(8):705\u2013719. doi: 10.3109\/15563650.2011.615318","journal-title":"Clin Toxicol (Phila)"},{"issue":"7","key":"1057_CR54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jms.1777","volume":"45","author":"H Horai","year":"2010","unstructured":"Horai H, Arita M, Kanaya S et al (2010) MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom 45(7):703\u2013714. doi: 10.1002\/jms.1777","journal-title":"J Mass Spectrom"},{"issue":"2","key":"1057_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3408\/jasti.9.165","volume":"9","author":"H Inoue","year":"2004","unstructured":"Inoue H, Iwata YT, Kanamori T et al (2004) Analysis of benzylpiperazine-like compounds. Jpn J Sci Tech Identif 9(2):165\u2013184","journal-title":"Jpn J Sci Tech Identif"},{"issue":"2","key":"1057_CR56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5507\/bp.2010.017","volume":"154","author":"P Jancova","year":"2010","unstructured":"Jancova P, Anzenbacher P, Anzenbacherova E (2010) Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(2):103\u2013116","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"8","key":"1057_CR57","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0269881107077260","volume":"21","author":"AC Johnstone","year":"2007","unstructured":"Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS (2007) Benzylpiperazine: a drug of abuse? J Psychopharmacol 21(8):888\u2013894. doi: 10.1177\/0269881107077260","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1057_CR58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1570-0232(04)00592-6","volume":"810","author":"A Kankaanpaa","year":"2004","unstructured":"Kankaanpaa A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T (2004) Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed 810(1):57\u201368. doi: 10.1016\/j.jchromb.2004.07.035","journal-title":"J Chromatogr B Analyt Technol Biomed"},{"key":"1057_CR59","volume-title":"\u201cLegal highs\u201d\u2014analysis of tablets and capsules containing piperazines","author":"S Kenyon","year":"2007","unstructured":"Kenyon S, Button J, Ramsey J, Holt DW (2007) \u201cLegal highs\u201d\u2014analysis of tablets and capsules containing piperazines. University of London, Poster"},{"issue":"1","key":"1057_CR60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/03036758.2011.557036","volume":"41","author":"JR Kerr","year":"2011","unstructured":"Kerr JR, Davis LS (2011) Benzylpiperazine in New Zealand: brief history and current implications. J R Soc N Z 41(1):155\u2013164. doi: 10.1080\/03036758.2011.557036","journal-title":"J R Soc N Z"},{"issue":"3","key":"1057_CR61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-009-1669-2","volume":"207","author":"JC Lin","year":"2009","unstructured":"Lin JC, Bangs N, Lee H, Kydd RR, Russell BR (2009) Determining the subjective and physiological effects of BZP on human females. Psychopharmacology 207(3):439\u2013446. doi: 10.1007\/s00213-009-1669-2","journal-title":"Psychopharmacology"},{"issue":"9","key":"1057_CR62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/dta.285","volume":"3","author":"JC Lin","year":"2011","unstructured":"Lin JC, Jan RK, Kydd RR, Russell BR (2011a) Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Test Anal 3(9):582\u2013585. doi: 10.1002\/dta.285","journal-title":"Drug Test Anal"},{"issue":"3","key":"1057_CR63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00213-010-2081-7","volume":"214","author":"JC Lin","year":"2011","unstructured":"Lin JC, Jan RK, Lee H, Jensen MA, Kydd RR, Russell BR (2011b) Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology 214(3):761\u2013768. doi: 10.1007\/s00213-010-2081-7","journal-title":"Psychopharmacology"},{"key":"1057_CR64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(86)90271-2","volume":"130","author":"K Magyar","year":"1986","unstructured":"Magyar K, Fekete M, Tekes K, T\u00f6r\u00f6k T (1986) The action of trebilet, a new antidepressive agent on [3H]noradrenaline release from rabbit pulmonary artery. Eur J Pharmacol 130:219\u2013227","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1057_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-200404000-00007","volume":"26","author":"HH Maurer","year":"2004","unstructured":"Maurer HH, Kraemer T, Springer D, Staack RF (2004) Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit 26(2):127\u2013131","journal-title":"Ther Drug Monit"},{"issue":"4","key":"1057_CR66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1742-7843.2006.pto_243.x","volume":"98","author":"E Meririnne","year":"2006","unstructured":"Meririnne E, Kajos M, Kankaanpaa A, Seppala T (2006) Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats. Basic Clin Pharmacol Toxicol 98(4):346\u2013350. doi: 10.1111\/j.1742-7843.2006.pto_243.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1057_CR67","doi-asserted-by":"crossref","unstructured":"Mohandas A, Vecchio D (2008) A case report of benzylpiperazine induced new onset affective symptoms in a patient with schizophrenia. Eur Psychiatry 23(S2):315\u2013316","DOI":"10.1016\/j.eurpsy.2008.01.1085"},{"key":"1057_CR68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2011.12.004","volume":"61","author":"IE Moreno","year":"2012","unstructured":"Moreno IE, da Fonseca BM, Barroso M, Costa S, Queiroz JA, Gallardo E (2012a) Determination of piperazine-type stimulants in human urine by means of microextraction in packed sorbent and high performance liquid chromatography-diode array detection. J Pharm Biomed Anal 61:93\u201399. doi: 10.1016\/j.jpba.2011.12.004","journal-title":"J Pharm Biomed Anal"},{"key":"1057_CR69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.chroma.2011.12.016","volume":"1222","author":"IE Moreno","year":"2012","unstructured":"Moreno IE, da Fonseca BM, Magalhaes AR et al (2012b) Rapid determination of piperazine-type stimulants in human urine by microextraction in packed sorbent after method optimization using a multivariate approach. J Chromatogr A 1222:116\u2013120. doi: 10.1016\/j.chroma.2011.12.016","journal-title":"J Chromatogr A"},{"issue":"1293","key":"1057_CR70","first-page":"3564","volume":"122","author":"M Murphy","year":"2009","unstructured":"Murphy M, Antia U, Chang HY et al (2009) Party pills and drug\u2013drug interactions. N Z Med J 122(1293):3564","journal-title":"N Z Med J"},{"issue":"2\u20133","key":"1057_CR71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559(2\u20133):132\u2013137. doi: 10.1016\/j.ejphar.2006.11.075","journal-title":"Eur J Pharmacol"},{"key":"1057_CR72","doi-asserted-by":"crossref","unstructured":"Nikolova I, Danchev N (2008) Piperazine based substances of abuse: a new party pills on bulgarian drug market. Biotechnol Biotechnol Equip 22(2):652\u2013655","DOI":"10.1080\/13102818.2008.10817529"},{"key":"1057_CR73","unstructured":"Perry J (2008) Adulthood outcomes in rats following repeated adolescent exposure to 1-benzylpiperazine (BZP) and\/or ethanol. Dissertation, University of Canterbury"},{"issue":"6","key":"1057_CR74","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jms.483","volume":"38","author":"FT Peters","year":"2003","unstructured":"Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography\/mass spectrometry. J Mass Spectrom 38(6):659\u2013676. doi: 10.1002\/jms.483","journal-title":"J Mass Spectrom"},{"issue":"10","key":"1057_CR75","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/qjmed\/hcq132","volume":"103","author":"J Ramsey","year":"2010","unstructured":"Ramsey J, Dargan PI, Smyllie M et al (2010) Buying \u2018legal\u2019 recreational drugs does not mean that you are not breaking the law. Q J Med 103(10):777\u2013783. doi: 10.1093\/qjmed\/hcq132","journal-title":"Q J Med"},{"issue":"3","key":"1057_CR76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15563650.2011.572076","volume":"49","author":"LJ Schep","year":"2011","unstructured":"Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P (2011) The clinical toxicology of the designer \u201cparty pills\u201d benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol (Phila) 49(3):131\u2013141. doi: 10.3109\/15563650.2011.572076","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"1057_CR77","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.pnpbp.2005.11.035","volume":"30","author":"F Schifano","year":"2006","unstructured":"Schifano F, Deluca P, Baldacchino A et al (2006) Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry 30(4):640\u2013646. doi: 10.1016\/j.pnpbp.2005.11.035","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20133","key":"1057_CR78","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2010.06.030","volume":"206","author":"MM Schmidt","year":"2011","unstructured":"Schmidt MM, Sharma A, Schifano F, Feinmann C (2011) \u201cLegal highs\u201d on the net-evaluation of UK-based Websites, products and product information. Forensic Sci Int 206(1\u20133):92\u201397. doi: 10.1016\/j.forsciint.2010.06.030","journal-title":"Forensic Sci Int"},{"key":"1057_CR79","volume-title":"Legal party pills and their use by young people in New Zealand: a qualitative study. Final report of findings","author":"J Sheridan","year":"2007","unstructured":"Sheridan J, Butler R (2007) Legal party pills and their use by young people in New Zealand: a qualitative study. Final report of findings. University of Auckland, Auckland"},{"issue":"1","key":"1057_CR80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugpo.2009.02.002","volume":"21","author":"J Sheridan","year":"2010","unstructured":"Sheridan J, Butler R (2010) \u201cThey\u2019re legal so they\u2019re safe, right?\u201d What did the legal status of BZP-party pills mean to young people in New Zealand? In J Drug Policy 21(1):77\u201381. doi: 10.1016\/j.drugpo.2009.02.002","journal-title":"In J Drug Policy"},{"issue":"3","key":"1057_CR81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09595230701255791","volume":"26","author":"J Sheridan","year":"2007","unstructured":"Sheridan J, Butler R, Wilkins C, Russell B (2007) Legal piperazine-containing party pills\u2014a new trend in substance misuse. Drug Alcohol Rev 26(3):335\u2013343. doi: 10.1080\/09595230701255791","journal-title":"Drug Alcohol Rev"},{"key":"1057_CR82","unstructured":"Sheridan J, Butler R, Dong CY, Barnes J (2009) Legally available, unclassified psychoactive substances and illegal drugs in New Zealand before and after the ban of BZP: a web-based survey of patterns of use. http:\/\/www.ndp.govt.nz\/moh.nsf\/pagescm\/7615\/$File\/web-survey-24Aug09.pdf . Accessed 21 July 2012"},{"issue":"9571","key":"1057_CR83","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(07)60646-1","volume":"369","author":"RF Staack","year":"2007","unstructured":"Staack RF (2007) Piperazine designer drugs of abuse. Lancet 369(9571):1411\u20131413. doi: 10.1016\/s0140-6736(07)60646-1","journal-title":"Lancet"},{"issue":"3","key":"1057_CR84","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1389200054021825","volume":"6","author":"RF Staack","year":"2005","unstructured":"Staack RF, Maurer HH (2005) Metabolism of designer drugs of abuse. Curr Drug Metab 6(3):259\u2013274","journal-title":"Curr Drug Metab"},{"issue":"1","key":"1057_CR85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(01)00619-5","volume":"773","author":"RF Staack","year":"2002","unstructured":"Staack RF, Fritschi G, Maurer HH (2002) Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 773(1):35\u201346","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1057_CR86","unstructured":"Thompson I, Williams G, Aldington S et al (2006) Report for the Ministry of Health: the benzylpiperazine (BZP)\/trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study. Wellington, New Zealand"},{"issue":"2","key":"1057_CR87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jchromb.2005.02.016","volume":"819","author":"H Tsutsumi","year":"2005","unstructured":"Tsutsumi H, Katagi M, Miki A et al (2005) Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine. J Chromatogr B Analyt Biomed Life Sci 819(2):315\u2013322. doi: 10.1016\/j.jchromb.2005.02.016","journal-title":"J Chromatogr B Analyt Biomed Life Sci"},{"issue":"1","key":"1057_CR88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jat\/30.1.38","volume":"30","author":"H Tsutsumi","year":"2006","unstructured":"Tsutsumi H, Katagi M, Miki A et al (2006) Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat. J Anal Toxicol 30(1):38\u201343","journal-title":"J Anal Toxicol"},{"issue":"6","key":"1057_CR89","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/32.6.444","volume":"32","author":"SP Vorce","year":"2008","unstructured":"Vorce SP, Holler JM, Levine B, Past MR (2008) Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS. J Anal Toxicol 32(6):444\u2013450","journal-title":"J Anal Toxicol"},{"key":"1057_CR90","unstructured":"WADA (2006) World Anti-Doping Agency. The world anti-doping code\u2014the 2007 Prohibited List International Standard. http:\/\/www.dis-sportschiedsgericht.de\/Material\/DLV\/IAAF\/IAAF_Prohibited_List_2007.pdf . Accessed 12 Mar 2012"},{"issue":"1","key":"1057_CR91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bmc.1619","volume":"26","author":"M Wada","year":"2012","unstructured":"Wada M, Yamahara K, Ikeda R, Kikura-Hanajiri R, Kuroda N, Nakashima K (2012) Simultaneous determination of N-benzylpiperazine and 1-(3-trifluoromethylphenyl)piperazine in rat plasma by HPLC-fluorescence detection and its application to monitoring of these drugs. Biomed Chromatogr 26(1):21\u201325. doi: 10.1002\/bmc.1619","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"1057_CR92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jat\/28.1.67","volume":"28","author":"M Wikstrom","year":"2004","unstructured":"Wikstrom M, Holmgren P, Ahlner J (2004) A2 (N-benzylpiperazine) a new drug of abuse in Sweden. J Anal Toxicol 28(1):67\u201370","journal-title":"J Anal Toxicol"},{"key":"1057_CR93","doi-asserted-by":"crossref","unstructured":"Wilkins C, Sweetsur P (2012) The impact of the prohibition of benzylpiperazine (BZP) \u2018legal highs\u2019 on the prevalence of BZP, new legal highs and other drug use in New Zealand. Drug Alcohol Depend doi: 10.1016\/j.drugalcdep.2012.06.014","DOI":"10.1016\/j.drugalcdep.2012.06.014"},{"key":"1057_CR94","volume-title":"Legal party pill use in New Zealand: prevalence of use, availability, health harms and \u201cgateway effects\u201d of benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP)","author":"C Wilkins","year":"2006","unstructured":"Wilkins C, Girling M, Sweetsur P, Huckle T, Huakau J (2006) Legal party pill use in New Zealand: prevalence of use, availability, health harms and \u201cgateway effects\u201d of benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP). Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University, Auckland"},{"issue":"6","key":"1057_CR95","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/09595230801956140","volume":"27","author":"C Wilkins","year":"2008","unstructured":"Wilkins C, Sweetsur P, Girling M (2008) Patterns of benzylpiperazine\/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand. Drug Alcohol Rev 27(6):633\u2013639. doi: 10.1080\/09595230801956140","journal-title":"Drug Alcohol Rev"},{"key":"1057_CR96","doi-asserted-by":"crossref","unstructured":"Winstock AR, Ramsey JD (2010) Legal highs and the challenges for policy makers. Addiction. doi: 10.1111\/j.1360-0443.2010.02934.x","DOI":"10.1111\/j.1360-0443.2010.02934.x"},{"issue":"9571","key":"1057_CR97","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(07)60674-6","volume":"369","author":"DM Wood","year":"2007","unstructured":"Wood DM, Dargan PI, Button J et al (2007) Collapse, reported seizure\u2014and an unexpected pill. Lancet 369(9571):1490. doi: 10.1016\/s0140-6736(07)60674-6","journal-title":"Lancet"},{"issue":"4","key":"1057_CR98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF03161209","volume":"4","author":"DM Wood","year":"2008","unstructured":"Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI (2008) Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol 4(4):254\u2013257","journal-title":"J Med Toxicol"},{"issue":"1","key":"1057_CR99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pbb.2007.06.007","volume":"88","author":"HL Yarosh","year":"2007","unstructured":"Yarosh HL, Katz EB, Coop A, Fantegrossi WE (2007) MDMA-like behavioral effects of N-substituted piperazines in the mouse. Pharmacol Biochem Behav 88(1):18\u201327. doi: 10.1016\/j.pbb.2007.06.007","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"1057_CR100","first-page":"38","volume":"1","author":"CW Yeap","year":"2010","unstructured":"Yeap CW, Bian CK, Abdullah AFL (2010) A review on benzylpiperazine and trifluoromethylphenylpiperazine: origins, effects, prevalence and legal status. Health Environ J 1(2):38\u201350","journal-title":"Health Environ J"},{"issue":"2","key":"1057_CR101","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874473711104020122","volume":"4","author":"JB Zawilska","year":"2011","unstructured":"Zawilska JB (2011) \u201cLegal highs\u201d\u2014new players in the old drama. Curr Drug Abuse Rev 4(2):122\u2013130","journal-title":"Curr Drug Abuse Rev"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-013-1057-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1057-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T07:50:12Z","timestamp":1645084212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-013-1057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,18]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1007\/s00204-013-1057-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,18]]}}}